/biz/ - Business & Finance

>>19438013
I know this is a faggot FUDder, but I'm genuinely curious.
I bought v1 in the first pump and now hold just a few thousand v3. Feeling burnt but optimistic, a weird first feeling.
Thinking of throwing another ETH at this. What are the potential technical fuckups that could bog us all?

AMD MISSED
HOLY SHIT
AHAHAHAHAHA

AMD RYZEN THE FUCK DOWN KEK

AAAAAAAAAAAAAAAAAAAAA

I FINALLY UNDERSTAND WHY THE BEARS ARE ALWAYS SO SEEEETHING!!

>>18357477
>CHK
probably but how much of the float is short?

Trimming and exiting positions today. NOT because of any bearishness, but because I need to refocus. I would love to add Clorox but there's just too many positions. Need to free up some dry powder, I'm way over extended.

Trimmed: LHX, TACO, GO
Sell: LABU

Anyone know what's up with LDOS? Shit, no, gotta focus. LMT is better.

>AMRN
AMRN news from muh Schwab feed
>AMRN

BUZZ-Street View: Amarin could make billions on new approval, despite label wording
8:28 AM ET, 11/15/2019 - Reuters
** An FDA advisory panel voted unanimously to grant drugmaker approval to extend the label of its heart drug Vascepa as an add-on therapy for patients at high risk of heart attacks and strokes

** However, FDA's expert panel was split 50-50 on whether the drug label should also be extended to patients who have not previously had a cardiovascular disease or stroke; FDA expected to settle debate before Dec 28 deadline

LABEL DEBATE DOESN'T REALLY MATTER

** Jefferies ("buy", PT: $30) in a note titled "approval coming ... label debate doesn't really matter" says it would still not be surprised if stock was volatile on questions related to its label

>$30? Shit I wish I'd bought premarket... or held those shares I bought and flipped in my IRA

** Brokerage adds that FDA may choose to cover only high-risk patients with history of the disease, and leave it up to doctors to decide whether they should also use it for patients with no history of the disease

** Citigroup also believes that physicians will use Vascepa in very high risk patients regardless of the wording of the label

** Stifel ("buy") notes that even excluding patients with no established cardiovascular event, Vascepa's broader label can reach 10-15 mln patients and generate ~$3 bln for AMRN (Reporting by Ruhi Soni)

>In other news, I'm a stupid fuck.

brap.me/Smellbottoms

>>158212

Ah damn, can't have the wallet part be computer based or something? IE load/withdraw coins on a website, then play games on the phone to actually bet them? probably not, I guess, hah

Does Ᵽanda have any kind of slogan?

Previous thread:>>138290

I have panda, but dont have enough doges. name your price.

5k doges for 150'000 PND ?

>>46606
I just have two adress, to preserve my anonymous
>mfw I am legion

>>39311
shit no okay, added more nodes and now working

This is perfect, wolong chills will never be able to find our new home :3